Inflammatory bowel disease in children and adolescents

MJ Rosen, A Dhawan, SA Saeed - JAMA pediatrics, 2015 - jamanetwork.com
The inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn disease, are
chronic inflammatory disorders of the gastrointestinal tract most often diagnosed in …

[HTML][HTML] Diagnosis and management of autoimmune hepatitis: current status and future directions

AJ Czaja - Gut and liver, 2016 - ncbi.nlm.nih.gov
Autoimmune hepatitis is characterized by autoantibodies, hypergammaglobulinemia, and
interface hepatitis on histological examination. The features lack diagnostic specificity, and …

ECCO guidelines on inflammatory bowel disease and malignancies

H Gordon, L Biancone, G Fiorino… - Journal of Crohn's …, 2023 - academic.oup.com
This guideline is the second European Crohn's and Colitis Organisation [ECCO] evidence-
based consensus on inflammatory bowel disease [IBD] and malignancy, and is an update …

Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?

G Monteleone, S Ardizzone - Journal of Crohn's and Colitis, 2020 - academic.oup.com
Crohn's disease [CD] and ulcerative colitis [UC], the main inflammatory bowel diseases [IBD]
in humans, are chronic, immune-inflammatory diseases, the pathogenesis of which suggests …

The real-world effectiveness and safety of vedolizumab for moderate–severe Crohn's disease: results from the US VICTORY Consortium

PS Dulai, S Singh, X Jiang, F Peerani… - Official journal of the …, 2016 - journals.lww.com
The Real-World Effectiveness and Safety of Vedolizumab for M... : Official journal of the American
College of Gastroenterology | ACG The Real-World Effectiveness and Safety of Vedolizumab for …

Pediatric inflammatory bowel disease

M Bouhuys, WS Lexmond, PF van Rheenen - Pediatrics, 2023 - publications.aap.org
Inflammatory bowel diseases (IBDs) are chronic, immune-mediated disorders that include
Crohn's disease and ulcerative colitis. A pediatric onset of disease occurs in about 10% of …

Preventing COVID-19-induced pneumonia with anticytokine therapy

G Monteleone, PC Sarzi-Puttini… - The Lancet …, 2020 - thelancet.com
March 23. DOI: 10.1093/ofid/ofaa105. 5 Wu C, Chen X, Cai Y, et al. Risk factors associated
with acute respiratory distress syndrome and death in patients with coronavirus disease …

Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease

JS Hyams, MC Dubinsky, RN Baldassano, RB Colletti… - Gastroenterology, 2017 - Elsevier
Background and Aims Immunosuppressive therapy for inflammatory bowel disease (IBD) in
pediatric patients is thought to increase the risk of malignancy and lymphoproliferative …

Diagnosis and management of inflammatory bowel disease in children

SB Oliveira, IM Monteiro - Bmj, 2017 - bmj.com
Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are
lifelong conditions that often begin in childhood. The implications of IBD are of particular …

The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD

MW Carroll, ME Kuenzig, DR Mack… - Journal of the …, 2019 - academic.oup.com
Canada has among the highest rates of childhood-onset IBD in the world. Over 7000
children and youth under 18 years old are living with IBD in Canada, and 600 to 650 …